Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting safety, tolerability, pharmacokinetics, and pharmacodynamics of TB31F for malaria caused by Plasmodium falciparum; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• TB31F

Snippet

Sponsor: Radboud University Medical Center | Conditions: Malaria,Falciparum | Phase 1 | Status: COMPLETED | Results posted: 2023-03-27